Research into attitudes towards starting treatment early

The H-TEAM’s research aimed to gain insight into the perceptions of, as well as the motivating and demotivating factors for, starting treatment early (in case of a CD4 count of over 500) among people living with HIV and HIV practitioners.
snelstarten

What research methods were used?

The research comprised interviews with thirteen HIV-positive patients – who had a CD4 count over 500 cells/m3 at the moment of diagnosis – and sixteen HIV practitioners, among whom nine internist-infectious diseases specialists and seven HIV counsellors. The intention was to investigate a group of participants which was as diverse as possible (in terms of gender, age, ethnicity and attitude towards early starting) to give a broad overview of the factors that play a role in the decision-making process of starting treatment early or not.

Aim of the research

The H-TEAM’s research aimed to gain insight into the perceptions of, as well as the motivating and demotivating factors for, starting treatment early (in case of a CD4 count of over 500) among people living with HIV and HIV practitioners.

waarom-w

Why this investigation?

The potential advantages of starting antiretroviral therapy (ART) early – such as the prevention of health loss and virus transmissions – are largely determined by the willingness of HIV patients and HIV practitioners (to advise) to start treatment in case of a high CD4 count

Read more >>

aanpakken-w

What research methods were used?

The research comprised interviews with thirteen HIV-positive patients – who had a CD4 count over 500 cells/m3 at the moment of diagnosis – and sixteen HIV practitioners, among whom nine internist-infectious diseases specialists and seven HIV counsellors.

Read more >>

resultaat-w

Research results:

The majority of practitioners and patients appeared to feel positive about early treatment, and they quickly started treatment (or advised their patients to do so). The ideas and decision-making processes related to early treatment were influenced by treatment-related factors and patient-related factors.

Read more >>

Work package participants

Prof. Dr Suzanne (S.E.) Geerlings, Internal Medicine, Academic Medical Center, Amsterdam (AMC)

Prof. Dr Jan (J.M.) Prins, Internal Medicine, Academic Medical Center, Amsterdam (AMC)

Anne (A.) van Puffelen, Amsterdam Institute for Global Health and Development (AIGHD)

Team

  • Anne van Puffelen
    Anne van Puffelen

    Member
    AIGHD

  • Marijn de Bruin
    Marijn de Bruin

    Member
    UvA

  • Suzanne Geerlings
    Suzanne Geerlings

    Project Leader
    AMC

  • Jan Prins
    Jan Prins

    Project Leader
    AMC